1. Pharmaceuticals and Drug Development

Pierre Fabre Pharmaceuticals Inc. Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Tabelecleucel for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)

Written by Posted on Less than 0 min read

SECAUCUS, N.J., July 24, 2025 /PRNewswire/ — Pierre Fabre Pharmaceuticals Inc. (PFP) announces the acceptance by U.S. Food and Drug Administration (FDA) of the Biologics License Application (BLA) and Priority Review of tabelecleucel, indicated as…

Member since

More from Admin

Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Microorganisms can travel long distances in the troposphere

Analysis of air samples taken at altitudes of up to 3,000 metres above Japan has revealed the presence of a vast range of viable bacteria and fungi transported by air masses originating more than 2,000 kilometres away, in regions enriched with fertilisers and pesticides. The study, published in Proceedings of the National Academy of Sciences […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Near chromosome-level genome of the Mojave poppy bee

Scientists at the United States Department of Agriculture (USDA)’s Agricultural Research Service (ARS) and university research partners developed a near chromosome-level genome for the Mojave poppy bee, a specialist pollinator of conservation concern, according to a recent Journal of Heredity paper. Putting together the Mojave poppy bee genome is part of the Beenome100 project, a […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Healthy eating in midlife linked to overall healthy aging

Maintaining a healthy diet rich in plant-based foods, with low to moderate intake of healthy animal-based foods and lower intake of ultra-processed foods, was linked to a higher likelihood of healthy aging — defined as reaching age 70 free of major chronic diseases and with cognitive, physical, and mental health maintained, according to a new […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Genetic tracing at the Huanan Seafood market further supports COVID animal origins

A new international collaborative study provides a list of the wildlife species present at the market from which SARS-CoV-2, the virus responsible for the COVID-19 pandemic, most likely arose in late 2019. The study is based on a new analysis of metatranscriptomic data released by the Chinese Center for Disease Control and Prevention (CDC). The […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Mimicking a bird’s sticky spit to create cellulose gels

Using a small bird’s nest-making process as a model, researchers from North Carolina State University have developed a nontoxic process for making cellulose gels. The freeze-thaw process is simple, cost-effective, and can create cellulose gels that are useful in a number of applications, including tunable gels for timed drug delivery. The process also works with […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Rotavirus protein NSP4 manipulates gastrointestinal disease severity

Researchers at Baylor College of Medicine and collaborating institutions have improved our understanding of how rotavirus, the most common cause of acute gastroenteritis in children, makes people sick. The study published in Science Advances is among the first to show that the rotavirus protein NSP4 is both necessary and sufficient for multiple aspects of rotavirus […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Warmth stress from ocean warming harms octopus imaginative and prescient

Whereas local weather change has led to a rise within the abundance of octopuses, warmth stress from projected ocean warming may impair their imaginative and prescient and affect the survivability of the species. “We discovered a number of proteins essential for imaginative and prescient that have been affected by thermal stress,” says Dr Qiaz Hua, […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

First fossil evidence of endangered tropical tree discovered

For the first time, scientists have discovered fossil evidence of an endangered, living tropical tree species. The unprecedented find was made in Brunei, a country on the large island of Borneo, and reveals a critical piece of the ancient history of Asia’s rainforests, highlighting the urgent need for conservation in the region, according to researchers […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

Cancer cells may be using lipids to hide from the immune system

Cancer cells seldom start off stealthy. Quite to the contrary, they announce their presence to the immune system by planting chemical red flags right on their membranes. Once alerted, the body’s defenses can swoop in, destroying rogue cells before they can do much damage. Lying at the heart of this early warning system are lipids, […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

When inequality is greater than ‘skin-deep’: Social standing leaves traces within the epigenome of noticed hyenas in Tanzania

A analysis consortium led by scientists from the Leibniz Institute for Zoo and Wildlife Analysis (Leibniz-IZW) present proof that social behaviour and social standing are mirrored on the molecular degree of gene activation (epigenome) in juvenile and grownup free-ranging noticed hyenas. They analysed non-invasively collected intestine epithelium samples from each high-ranking and low-ranking feminine hyenas […]
Written by
Scientists uncover new way viruses fight back against bacteria
  1. Life Sciences

A plant you’ve never heard of can do what scientists once thought impossible

About 3.7 billion years ago, a string of naturally occurring amino — the same kind that astronomers have found in meteorites and just recently in a stellar nursery near the center of the Milky Way Galaxy — reacted with a naturally occurring catalyst and began the fateful process of self-assembled replication. One of the most […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

First Person With Cystic Fibrosis Dosed In Phase 1 Trial Of Investigational Therapy Cm001, Designed To Form Ion Channels To Help Restore Airway Function

CHAMPAIGN, Ill., Oct. 30, 2023. cystetic Medicines, Inc., a clinical-stage biotechnology company developing small molecule channels that serve as molecular prosthetics for missing or dysfunctional CFTR protein channels, announced today it has dosed the first person with cystic fibrosis (CF) as part of an ongoing Phase 1 clinical trial (NCT05802264) of its investigational inhalable small […]
Written by
  1. Clinical

Takeda Presents Late-Breaking Data from Phase 2b Study of Mezagitamab, Demonstrating Potential to Transform Treatment of Primary Immune Thrombocytopenia

OSAKA, Japan and CAMBRIDGE, Massachusetts, June 22, 2024 – Takeda (TSE:4502/NYSE:TAK) today presented positive results from its Phase 2b, randomized, double-blind, placebo-controlled study evaluating the safety, tolerability and efficacy of mezagitamab (TAK-079) in patients with persistent or chronic primary immune thrombocytopenia (ITP), a rare immune-mediated bleeding disorder. ITP is characterized by the accelerated destruction of […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Clinical

FDA Clears Application to Initiate Phase 1 Clinical Study of oral Immunotherapy for the Treatment of Rheumatoid Arthritis

ROCKVILLE, Md., Oct. 19, 2023. – Rise Therapeutics, a biotechnology company engaged in developing novel oral immunotherapeutics, today announced that the U.S. Food and Drug Administration (FDA) has accepted its investigational new drug (IND) application to proceed with a rheumatoid arthritis Phase 1 clinical trial for its program candidate, R-2487. This is Rise Therapeutics’ second […]
Written by
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
  1. Pharmaceuticals and Drug Development

U.S. Meals and Drug Administration (FDA) Has Accepted the New Drug Software (NDA) for Ensartinib

Therapy for: Non-Small Cell Lung Most cancers U.S. Meals and Drug Administration (FDA) Has Accepted the New Drug Software (NDA) for Ensartinib MIAMI–(BUSINESS WIRE) March 13, 2024 –Xcovery Holdings, Inc., an oncology centered pharmaceutical firm, as we speak introduced that the U.S. Meals and Drug Administration (FDA) has accepted the New Drug Software (NDA) for […]
Written by
CDC Urges Clinicians to Remain on the Lookout for Mpox Virus Infections
  1. Pharmaceuticals and Drug Development

CDC Urges Clinicians to Remain on the Lookout for Mpox Virus Infections

Medically reviewed by Drugs.com. By Elana Gotkine HealthDay Reporter THURSDAY, June 6, 2024 — Among emergency department patients evaluated for an mpox-compatible rash, the prevalence of mpox is 1.5 percent, according to research published in the June 6 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report. Carl T. […]
Written by
  1. Biology

Pex30-dependent membrane contact sites maintain ER lipid homeostasis

In eukaryotic cells, communication between organelles and the coordination of their activities depend on membrane contact sites (MCS). How MCS are regulated under the dynamic cellular environment remains poorly understood. Here, we investigate how Pex30, a membrane protein localized to the endoplasmic reticulum (ER), regulates multiple MCS in budding yeast. We show that Pex30 is […]
Written by
  1. Biology

PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways

Arsenic effectively treats acute promyelocytic leukemia by inducing SUMO and ubiquitin-dependent degradation of the promyelocytic leukemia (PML)–retinoic acid receptor alpha oncogenic fusion protein. However, some patients relapse with arsenic-resistant disease because of missense mutations in PML. To determine the mechanistic basis for arsenic resistance, PML−/− cells were reconstituted with YFP fusions of wild-type PML-V and […]
Written by
Next
No Comments
Leave a comment Cancel
Comments to: Pierre Fabre Pharmaceuticals Inc. Announces FDA Acceptance and Priority Review of the Biologics License Application (BLA) for Tabelecleucel for the Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)

Login

Welcome to Life Science News!
"Explore the Latest Discoveries and Breakthroughs in Life Science with Life Science News!"
Read Smart, Save Time
Pick all the topics you are interested in to fill your homepage with stories you'll love.
Join our community
Registration is closed.